Positive Clinical Outcomes for Severe Reported Pain Using Robust Non-Addictive Home Electrotherapy—A Case-Series

The North American opioid epidemic has resulted in over 800,000 related premature overdose fatalities since 2000, with the United States leading the world in highest opioid deaths per capita. Despite increased federal funding in recent years, intended to address this crisis, opioid overdose mortality has continued to increase. Legally prescribed opioids also chronically induce a problematic reduction in affect. While an ideal analgesic has yet to be developed, some effective multimodal non-opioid pharmacological regimens for acute pain management are being more widely utilized. Some investigators have suggested that a safer and more scientifically sound approach might be to induce “dopamine homeostasis” through non-pharmacological approaches, since opioid use even for acute pain of short duration is now being strongly questioned. There is also increasing evidence suggesting that some more robust forms of electrotherapy could be applied as an effective adjunct to avoid the problems associated with opioids. This 4-patient case-series presents such an approach to treatment of severe pain. All 4 of these chiropractic treatment cases involved a component of knee osteoarthritis, in addition to other reported areas of pain. Each patient engaged in a home recovery strategy using H-Wave® device stimulation (HWDS) to address residual extremity issues following treatment of spinal subluxation and other standard treatments. A simple statistical analysis was conducted to determine the change in pain scores (Visual Analogue Scale) of pre and post electrotherapy treatments, resulting in significant reductions in self-reported pain (p-value = 0.0002). Three of the four patients continued using the home therapy device long-term as determined by a post-analysis questionnaire. This small case-series demonstrated notably positive outcomes, suggesting consideration of home use of HWDS for safe, non-pharmacological and non-addictive treatment of severe pain.

[1]  David Han,et al.  Clinical and Quality of Life Benefits for End-Stage Workers’ Compensation Chronic Pain Claimants following H-Wave® Device Stimulation: A Retrospective Observational Study with Mean 2-Year Follow-Up , 2023, Journal of clinical medicine.

[2]  K. Blum,et al.  Should Reward Deficiency Syndrome (RDS) Be Considered an Umbrella Disorder for Mental Illness and Associated Genetic and Epigenetic Induced Dysregulation of Brain Reward Circuitry? , 2022, Journal of personalized medicine.

[3]  Ashim Gupta,et al.  Job-Related Performance and Quality of Life Benefits in First Responders Given Access to H-Wave® Device Stimulation: A Retrospective Cohort Study , 2022, Journal of personalized medicine.

[4]  David E. Smith,et al.  Proposing a “Brain Health Checkup (BHC)” as a Global Potential “Standard of Care” to Overcome Reward Dysregulation in Primary Care Medicine: Coupling Genetic Risk Testing and Induction of “Dopamine Homeostasis” , 2022, International journal of environmental research and public health.

[5]  K. Blum,et al.  Overcoming reward deficiency syndrome by the induction of “dopamine homeostasis” instead of opioids for addiction: illusion or reality? , 2022, Journal of osteopathic medicine.

[6]  K. Blum,et al.  Reward Deficiency Syndrome (RDS) Surprisingly Is Evolutionary and Found Everywhere: Is It “Blowin’ in the Wind”? , 2022, Journal of personalized medicine.

[7]  K. Blum,et al.  Development and validation of the Reward Deficiency Syndrome Questionnaire (RDSQ-29) , 2022, Journal of psychopharmacology.

[8]  A. Berényi,et al.  A Proposed Brain-, Spine-, and Mental- Health Screening Methodology (NEUROSCREEN) for Healthcare Systems: Position of the Society for Brain Mapping and Therapeutics. , 2022, Journal of Alzheimer's disease : JAD.

[9]  K. Blum,et al.  Hypothesizing in the Face of the Opioid Crisis Coupling Genetic Addiction Risk Severity (GARS) Testing with Electrotherapeutic Nonopioid Modalities Such as H-Wave Could Attenuate Both Pain and Hedonic Addictive Behaviors , 2022, International journal of environmental research and public health.

[10]  William B. Downs,et al.  Reward Deficiency Syndrome (RDS): A Cytoarchitectural Common Neurobiological Trait of All Addictions , 2021, International journal of environmental research and public health.

[11]  T. Williamson,et al.  H-Wave® Device Stimulation: A Critical Review , 2021, Journal of personalized medicine.

[12]  K. Blum,et al.  Neurobiology and Spirituality in Addiction Recovery. , 2021, Acta scientific neurology.

[13]  Y. Zang,et al.  High-frequency rTMS over the dorsolateral prefrontal cortex on chronic and provoked pain: A systematic review and meta-analysis , 2021, Brain Stimulation.

[14]  Stephanie H. Felgoise,et al.  A mental health professional survey of cognitive-behavioral therapy for the treatment of opioid use disorder. , 2021, Journal of clinical psychology.

[15]  Sandra L DiScala,et al.  Spiritual Healing in a Hospice Veteran Led to a Successful Opioid Taper: A Case Report , 2021, Journal of pain & palliative care pharmacotherapy.

[16]  G. Varrassi,et al.  Can NSAIDs and Acetaminophen Effectively Replace Opioid Treatment Options for Acute Pain? , 2021, Expert opinion on pharmacotherapy.

[17]  F. Schiffer Unilateral transcranial photobiomodulation for opioid addiction in a clinical practice: A clinical overview and case series. , 2020, Journal of psychiatric research.

[18]  B. Pradhan,et al.  Combining Ketamine, Brain Stimulation (rTMS) and Mindfulness Therapy (TIMBER) for Opioid Addiction , 2020, Cureus.

[19]  A. Rezai,et al.  Transcranial magnetic stimulation, deep brain stimulation, and other forms of neuromodulation for substance use disorders: Review of modalities and implications for treatment , 2020, Journal of the Neurological Sciences.

[20]  K. Alexander,et al.  Implementation of a Mindfulness Intervention for Women in Treatment for Opioid Use Disorder and Its Effects on Depression Symptoms , 2019, Issues in mental health nursing.

[21]  S. Bowen,et al.  Raja yoga meditation and medication-assisted treatment for relapse prevention: A pilot study. , 2019, Journal of substance abuse treatment.

[22]  N. Salari,et al.  The Effectiveness of Group Spiritual Intervention on Self-esteem and Happiness Among Men Undergoing Methadone Maintenance Treatment. , 1969, Current drug research reviews.

[23]  C. Eccleston,et al.  When pain gets stuck: the evolution of pain chronification and treatment resistance , 2018, Pain.

[24]  S. Meghani,et al.  Spirituality and Quality of Life in Black Patients With Cancer Pain. , 2018, Journal of pain and symptom management.

[25]  N. Parvin,et al.  Spiritual Well-Being and Associated Factors with Relapse in Opioid Addicts. , 2017, Journal of clinical and diagnostic research : JCDR.

[26]  D. Borsook,et al.  Neuroscience and Biobehavioral Reviews Reward Deficiency and Anti-reward in Pain Chronification , 2022 .

[27]  D. Borsook,et al.  Common Brain Mechanisms of Chronic Pain and Addiction , 2016, Neuron.

[28]  L. Cottler,et al.  Gender Differences in the Association Between Religion/Spirituality and Simultaneous Polysubstance Use (SPU) , 2016, Journal of Religion and Health.

[29]  K. Kampman,et al.  American Society of Addiction Medicine (ASAM) National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use , 2015, Journal of addiction medicine.

[30]  Margaret A. Madigan,et al.  NIDA-Drug Addiction Treatment Outcome Study (DATOS) Relapse as a Function of Spirituality/Religiosity , 2015, Journal of reward deficiency syndrome.

[31]  A. Dahan,et al.  Opioid-induced respiratory depression: reversal by non-opioid drugs , 2014, F1000prime reports.

[32]  Margaret A. Madigan,et al.  Can Genetic Testing Coupled with Enhanced Dopaminergic Activation Reduce Recidivism Rates in the Workers Compensation Legacy Cases? , 2014, Journal of alcoholism and drug dependence.

[33]  Andrew B. Newberg,et al.  The neuroscientific study of spiritual practices , 2014, Front. Psychol..

[34]  N. Volkow,et al.  Pain and suicidality: Insights from reward and addiction neuroscience , 2013, Progress in Neurobiology.

[35]  K. Blum,et al.  Correction: Long Term Suboxone™ Emotional Reactivity As Measured by Automatic Detection in Speech , 2013, PLoS ONE.

[36]  K. Blum,et al.  Long Term Suboxone™ Emotional Reactivity As Measured by Automatic Detection in Speech , 2013, PloS one.

[37]  L. Becerra,et al.  Pain and analgesia: The value of salience circuits , 2013, Progress in Neurobiology.

[38]  L. Piacentine Spirituality, Religiosity, Depression, Anxiety, and Drug-Use Consequences During Methadone Maintenance Therapy , 2013, Western journal of nursing research.

[39]  Matt Schiller,et al.  A model to identify patients at risk for prescription opioid abuse, dependence, and misuse. , 2012, Pain medicine.

[40]  D. Epstein,et al.  A Focus-Group Study on Spirituality and Substance-User Treatment , 2010, Substance use & misuse.

[41]  Thomas J. H. Chen,et al.  Hypothesizing that brain reward circuitry genes are genetic antecedents of pain sensitivity and critical diagnostic and pharmacogenomic treatment targets for chronic pain conditions. , 2009, Medical hypotheses.

[42]  M. Anglin,et al.  Effect of Religiosity and Spirituality on Drug Treatment Outcomes , 2009, The Journal of Behavioral Health Services & Research.

[43]  Gary M. Pollack,et al.  Opioid Tolerance Development: A Pharmacokinetic/Pharmacodynamic Perspective , 2008, The AAPS Journal.

[44]  Thomas J. H. Chen,et al.  The H-Wave® device is an effective and safe non-pharmacological analgesic for chronic pain: a meta-analysis , 2008, Advances in therapy.

[45]  Thomas J. H. Chen,et al.  The H-Wave® Device Induces NO-dependent Augmented Microcirculation and Angiogenesis, Providing Both Analgesia and Tissue Healing in Sports Injuries , 2008, The Physician and sportsmedicine.

[46]  M. Galanter,et al.  Assessment of spirituality and its relevance to addiction treatment. , 2007, Journal of substance abuse treatment.

[47]  Marnie E. Shaw,et al.  Reward‐aversion circuitry in analgesia and pain: Implications for psychiatric disorders , 2007, European journal of pain.

[48]  S. Avants,et al.  Spiritual beliefs, world assumptions, and HIV risk behavior among heroin and cocaine users. , 2003, Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors.

[49]  D. Kumar,et al.  Diabetic Peripheral Neuropathy: Effectiveness of electrotherapy and amitriptyline for symptomatic relief , 1998, Diabetes Care.

[50]  M. Alvaro,et al.  Beneficial effects of electrical stimulation on neuropathic symptoms in diabetes patients. , 1998, The Journal of foot and ankle surgery : official publication of the American College of Foot and Ankle Surgeons.

[51]  D. Kumar,et al.  Diabetic Peripheral Neuropathy: Amelioration of Pain With Transcutaneous Electrostimulation , 1997, Diabetes Care.